Targeting HDAC/OAZ1 axis with a novel inhibitor effectively reverses cisplatin resistance in non-small cell lung cancer.
Sun Y, Bao X, Ren Y, Jia L, Zou S, Han J, Zhao M, Han M, Li H, Hua Q, Fang Y, Yang J, Wu C, Chen G, Wang L.
Sun Y, et al. Among authors: han m, han j.
Cell Death Dis. 2019 May 24;10(6):400. doi: 10.1038/s41419-019-1597-y.
Cell Death Dis. 2019.
PMID: 31127087
Free PMC article.